Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11083823
Tissue-separating fatty acid adhesion barrier
granted -
US 11083788
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
granted -
US 11078239
Prefusion PIV F immunogens and their use
granted -
US 11078486
Compounds and methods for reducing ATXN2 expression
granted -
US 11078266
Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3
granted -
US 11078245
Colon and pancreas cancer peptidomimetics
granted -
US 11078250
High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof
granted -
US 11072629
Reprogramming of cellular adhesion
granted -
US 11053484
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
granted -
US 11052089
Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progression to a cancer stem cell phenotype
granted -
US 11046752
Serpin fusion polypeptides and methods of use thereof
granted -
US 11033494
Apparatuses containing an emulsion and methods of manufacture
granted -
US 11033570
Modulation of Lnc05 expression
granted -
US 11033623
Magnetic stem cell therapy for lesions
granted -
US 11026997
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11028392
Compositions and methods for inhibiting expression of the ALAS1 gene
granted -
US 11021710
Compounds and methods for reducing FXI expression
granted -
US 11021576
Polymeric stabilizing formulations
granted -
US 11021696
Nuclease-mediated regulation of gene expression
granted -
US 11014931
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator
granted -
US 11015205
Oligomeric vaccines from plants by S-Tag-S-protein fusions
granted -
US 11015200
Antisense-induced exon exclusion in myostatin
granted -
US 11007248
Suppression of allergic lung inflammation and hyperreactivity
granted -
US 11008325
Inhibitors of cancer invasion, attachment, and/or metastasis
granted